Green Alpha Advisors, LLC Cure Vac N.V. Transaction History
Green Alpha Advisors, LLC
- $112 Million
- Q4 2024
A detailed history of Green Alpha Advisors, LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 26,037 shares of CVAC stock, worth $85,140. This represents 0.08% of its overall portfolio holdings.
Number of Shares
26,037
Previous 27,319
4.69%
Holding current value
$85,140
Previous $80,000
10.0%
% of portfolio
0.08%
Previous 0.06%
Shares
14 transactions
Others Institutions Holding CVAC
# of Institutions
86Shares Held
10.5MCall Options Held
75.5KPut Options Held
33.5K-
Black Rock Inc. New York, NY2.25MShares$7.37 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.65MShares$5.39 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$5.13 Million10.6% of portfolio
-
Ubs Group Ag577KShares$1.89 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$1.64 Million0.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $613M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...